162 related articles for article (PubMed ID: 16680600)
1. Desmoplastic stromal reaction in medullary thyroid cancer-an intraoperative "marker" for lymph node metastases.
Scheuba C; Kaserer K; Kaczirek K; Asari R; Niederle B
World J Surg; 2006 May; 30(5):853-9. PubMed ID: 16680600
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
3. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma?
Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F
Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930
[TBL] [Abstract][Full Text] [Related]
4. Omission of lateral lymph node dissection in medullary thyroid cancer without a desmoplastic stromal reaction.
Niederle MB; Riss P; Selberherr A; Koperek O; Kaserer K; Niederle B; Scheuba C
Br J Surg; 2021 Mar; 108(2):174-181. PubMed ID: 33704404
[TBL] [Abstract][Full Text] [Related]
5. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
[TBL] [Abstract][Full Text] [Related]
6. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
7. Skip metastases in medullary thyroid carcinoma: a single-center experience.
Tavares MR; Michaluart P; Montenegro F; Arap S; Sodre M; Takeda F; Brandao L; Toledo S; Ferraz A
Surg Today; 2008; 38(6):499-504. PubMed ID: 18516528
[TBL] [Abstract][Full Text] [Related]
8. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
9. Central neck dissection in the management of sporadic medullary thyroid microcarcinoma.
Hamy A; Pessaux P; Mirallié E; Mucci-Hennekinne S; Gibelin H; Mor-Martinez C; de Calan L; Ronceray J; Kraimps JL
Eur J Surg Oncol; 2005 Sep; 31(7):774-7. PubMed ID: 15925476
[TBL] [Abstract][Full Text] [Related]
10. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma.
Kwon H; Kim WG; Sung TY; Jeon MJ; Song DE; Lee YM; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
J Surg Oncol; 2016 Feb; 113(2):152-8. PubMed ID: 26799259
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in medullary thyroid microcarcinomas.
Santrac N; Markovic I; Medic Milijic N; Goran M; Buta M; Djurisic I; Dzodic R
Endocr J; 2020 Mar; 67(3):295-304. PubMed ID: 31801918
[TBL] [Abstract][Full Text] [Related]
12. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
13. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer.
Hwang HS; Orloff LA
Laryngoscope; 2011 Mar; 121(3):487-91. PubMed ID: 21344423
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid microcarcinoma recommendations for treatment - a single-center experience.
Scheuba C; Kaserer K; Bieglmayer C; Asari R; Riss P; Drosten R; Niederle B
Surgery; 2007 Dec; 142(6):1003-10; discussion 1010.e1-3. PubMed ID: 18063088
[TBL] [Abstract][Full Text] [Related]
15. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection.
Moley JF; DeBenedetti MK
Ann Surg; 1999 Jun; 229(6):880-7; discussion 887-8. PubMed ID: 10363903
[TBL] [Abstract][Full Text] [Related]
16. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
17. Lymph node involvement in macroscopic medullary thyroid carcinoma.
Tamagnini P; Iacobone M; Sebag F; Marcy M; De Micco C; Henry JF
Br J Surg; 2005 Apr; 92(4):449-53. PubMed ID: 15672437
[TBL] [Abstract][Full Text] [Related]
18. Prediction of lateral lymph node metastases in medullary thyroid cancer.
Machens A; Hauptmann S; Dralle H
Br J Surg; 2008 May; 95(5):586-91. PubMed ID: 18300267
[TBL] [Abstract][Full Text] [Related]
19. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
20. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.
Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G
J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
